Similarly, glucagon-like peptide-1 (GLP-1) analogs bind to GLP-1 receptors, stimulating insulin release in a glucose-dependent manner while also slowing gastric emptying and promoting satiety
This product is not intended for human consumption, veterinary use, cosmetic use, diagnostic use, medical use, therapeutic use, supplementation, wellness use, performance enhancement, personal use, or administration to humans or animals
The authors reported that although 97% of the portal vein samples were positive for endotoxin as measured by a Limulus bioassay, only 9% of the patients had gut flora culturable from the portal vein
BB10 peptide is not intended to diagnose, treat, cure, or prevent any disease
KPV does not need to reach systemic circulation to be effective in the gut